M1761K mutation in the von Willebrand factor A3 domain associated with impaired collagen binding and without platelet dysfunction.
作者： D. M. Ong , H. Aumann , R. K. Andrews , E. E. Gardiner , S. E. Rodgers
DOI: 10.1111/HAE.12976
关键词: Plasma protein binding 、 Platelet 、 Endocrinology 、 Mutation 、 Phenotype 、 Protein domain 、 Heterozygote advantage 、 Medicine 、 Von Willebrand factor type C domain 、 Von Willebrand factor 、 Internal medicine
摘要:
sci-hub.se 参考文章(10)
V. H. FLOOD, C. A. LEDERMAN, J. S. WREN, P. A. CHRISTOPHERSON, K. D. FRIEDMAN, R. G. HOFFMANN, R. R. MONTGOMERY, Absent collagen binding in a VWF A3 domain mutant: utility of the VWF:CB in diagnosis of VWD Journal of Thrombosis and Haemostasis. ,vol. 8, pp. 1431- 1433 ,(2010) , 10.1111/J.1538-7836.2010.03869.X
Jean-Maurice Lavergne, Irène Juhan-Vague, Bernadette Obert, Ghislaine Cherel, Dominique Meyer, Jean-Pierre Girma, Anne-Sophie Ribba, Irmine Loisel, Ser968Thr mutation within the A3 domain of von Willebrand factor (VWF) in two related patients leads to a defective binding of VWF to collagen. Thrombosis and Haemostasis. ,vol. 86, pp. 848- 854 ,(2001) , 10.1055/S-0037-1616142
D. KEELING, J. BEAVIS, R. MARR, K. SUKHU, P. BIGNELL, A family with type 2M VWD with normal VWF:RCo but reduced VWF:CB and a M1761K mutation in the A3 domain. Haemophilia. ,vol. 18, ,(2012) , 10.1111/J.1365-2516.2011.02676.X
L. D. MORALES, C. MARTIN, M. A. CRUZ, The interaction of von Willebrand factor-A1 domain with collagen: mutation G1324S (type 2M von Willebrand disease) impairs the conformational change in A1 domain induced by collagen. Journal of Thrombosis and Haemostasis. ,vol. 4, pp. 417- 425 ,(2006) , 10.1111/J.1538-7836.2006.01742.X
Alberto Tosetto, Giancarlo Castaman, How I treat type 2 variant forms of von Willebrand disease. Blood. ,vol. 125, pp. 907- 914 ,(2015) , 10.1182/BLOOD-2014-08-551960
Anne F. Riddell, Keith Gomez, Carolyn M. Millar, Gillian Mellars, Saher Gill, Simon A. Brown, Megan Sutherland, Mike A. Laffan, Thomas A. J. McKinnon, Characterization of W1745C and S1783A: 2 novel mutations causing defective collagen binding in the A3 domain of von Willebrand factor. Blood. ,vol. 114, pp. 3489- 3496 ,(2009) , 10.1182/BLOOD-2008-10-184317
Miguel A Cruz, Huabing Yuan, Joseph R Lee, Robert J Wise, Robert I Handin, None, Interaction of the von Willebrand Factor (vWF) with Collagen LOCALIZATION OF THE PRIMARY COLLAGEN-BINDING SITE BY ANALYSIS OF RECOMBINANT vWF A DOMAIN POLYPEPTIDES Journal of Biological Chemistry. ,vol. 270, pp. 10822- 10827 ,(1995) , 10.1074/JBC.270.18.10822
V. H. FLOOD, J. C. GILL, P. A. CHRISTOPHERSON, D. B. BELLISSIMO, K. D. FRIEDMAN, S. L. HABERICHTER, S. R. LENTZ, R. R. MONTGOMERY, Critical von Willebrand factor A1 domain residues influence type VI collagen binding Journal of Thrombosis and Haemostasis. ,vol. 10, pp. 1417- 1424 ,(2012) , 10.1111/J.1538-7836.2012.04746.X
Jianlin Qiao, Simone M. Schoenwaelder, Kylie D. Mason, Huy Tran, Amanda K. Davis, Zane S. Kaplan, Shaun P. Jackson, Benjamin T. Kile, Robert K. Andrews, Andrew W. Roberts, Elizabeth E. Gardiner, Low adhesion receptor levels on circulating platelets in patients with lymphoproliferative diseases before receiving Navitoclax (ABT-263). Blood. ,vol. 121, pp. 1479- 1481 ,(2013) , 10.1182/BLOOD-2012-12-467415
Hanneke L Lankhof, Maggy van Hoeij, Marion E Schiphorst, Madelon Bracke, Ya-Ping Wu, Martin J W Ijsseldijk, Tom Vink, Philip G de Groot, Jan J Sixma, A3 domain is essential for interaction of von Willebrand factor with collagen type III. Thrombosis and Haemostasis. ,vol. 75, pp. 950- 958 ,(1996) , 10.1055/S-0038-1650400